Elucidating the role of DEPTOR in Alzheimer's disease

International Journal of Molecular Medicine

Volumn 34, Issue 5, 2014, Pages 1195-1200

  Davies, Julie ^a   Zachariades, Elena ^a   Rogers Broadway, Karly Rai ^a   Karteris, Emmanouil ^a  

^a BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

Alzheimer's disease; A peptide; DEP domain containing mTOR interacting protein; Mechanistic target of rapamycin

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BINDING PROTEIN; DEP DOMAIN CONTAINING MAMMALIAN TARGET OF RAPAMYCIN INTERACTING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); DEPTOR PROTEIN, HUMAN; MESSENGER RNA; MTOR PROTEIN, HUMAN; PEPTIDE FRAGMENT; SIGNAL PEPTIDE; TARGET OF RAPAMYCIN KINASE;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROPROTECTION; OCCIPITAL LOBE; POSTCENTRAL GYRUS; PRIMARY MOTOR CORTEX; PROTEIN EXPRESSION; AGED; BRAIN; CELL DIFFERENTIATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MIDDLE AGED; NERVE CELL PLASTICITY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BRAIN; CELL DIFFERENTIATION; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NEURONAL PLASTICITY; PEPTIDE FRAGMENTS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84907195023     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1895     Document Type: Article

References (36)

1. Pei JJ and Hugon J: mTOR-dependent signalling in Alzheimer's disease. J Cell Mol Med 12: 2525-2532, 2008.
2. Blennow K, de Leon MJ and Zetterberg H: Alzheimer's disease. Lancet 368: 387-403, 2006.
3. Brown EJ, Albers MW, Shin TB, Ichikawa K, Keith CT, Lane WS, et al: A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369: 756-758, 1994.
4. Dennis PB, Jaeschke A, Saitoh M, Fowler B, Kozma SC and Thomas G: Mammalian TOR: A homeostatic ATP sensor. Science 294: 1102-1105, 2001.
5. Wullschleger S, Loewith R and Hall MN: TOR signaling in growth and metabolism. Cell 124: 471-484, 2006.
6. Hoeffer CA and Klann E: mTOR signaling: At the crossroads of plasticity, memory and disease. Trends Neurosci 2: 67-75, 2010.
7. Sutton MA and Schuman EM: Dendritic protein synthesis, synaptic plasticity, and memory. Cell 127: 49-58, 2006.
8. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, et al: Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460: 392-395, 2009.
9. Selman C, Tullet JM, Wieser D, Irvine E, Lingard SJ, Choudhury AI, et al: Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science 326: 140-144, 2009.
10. Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, et al: Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. J Neurosci 28: 6926-6937, 2008.
11. Lafay-Chebassier C, Paccalin M, Page G, Barc-Pain S, Perault-Pochat MC, Gil R, et al: mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease. J Neurochem 94: 215-225, 2005.
12. Spilman P, Podlutskaya N, Hart MJ, Debnath J, Gorostiza O, Bredesen D, et al: Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS One 5: e9979, 2010.
13. Ma T, Hoeffer CA, Capetillo-Zarate E, Yu F, Wong H, Lin MT, et al: Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease. PLoS One 5: e12845, 2010.
14. Peterson TR, Laplante M, Thoreen CC, Sancak Y, Kang SA, Kuehl WM, et al: DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell 137: 873-886, 2009.
15. Proud CG: Dynamic balancing: DEPTOR tips the scales. J Mol Cell Biol 1: 61-63, 2009.
16. Foster H, Coley HM, Goumenou A, Pados G, Harvey A and Karteris E: Differential expression of mTOR signalling components in drug resistance in ovarian cancer. Anticancer Res 30: 3529-3534, 2010.
17. Liu M, Wilk SA, Wang A, Zhou L, Wang RH, Ogawa W, et al: Resveratrol inhibits mTOR signaling by promoting the interaction between mTOR and DEPTOR. J Biol Chem 285: 36387-36394, 2010.
18. Lopez-Miranda V, Soto-Montenegro ML, Vera G, Herradon E, Desco M and Abalo R: Resveratrol: A neuroprotective polyphenol in the Mediterranean diet. Rev Neurol 54: 349-356, 2012.
19. Li Z, Pang L, Fang F, Zhang G, Zhang J, Xie M, et al: Resveratrol attenuates brain damage in a rat model of focal cerebral ischemia via up-regulation of hippocampal Bcl-2. Brain Res 1450: 116-124, 2012.
20. Huang TC, Lu KT, Wo YY, Wu YJ and Yang YL: Resveratrol protects rats from Abeta-induced neurotoxicity by the reduction of iNOS expression and lipid peroxidation. PLoS One 6: e29102, 2011.
21. Mparmpakas D, Zachariades E, Goumenou A, Gidron Y and Karteris E: Placental DEPTOR as a stress sensor during pregnancy. Clin Sci (Lond) 122: 349-359, 2012.
22. Li X, An WL, Alafuzoff I, Soininen H, Winblad B and Pei JJ: Phosphorylated eukaryotic translation factor 4E is elevated in Alzheimer brain. Neuroreport 15: 2237-2240, 2004.
23. Steinerman JR, Irizarry M, Scarmeas N, Raju S, Brandt J, Albert M, et al: Distinct pools of beta-amyloid in Alzheimer disease-affected brain: A clinicopathologic study. Arch Neurol 65: 906-912, 2008.
24. Kuo YM, Emmerling MR, Vigo-Pelfrey C, Kasunic TC, Kirkpatrick JB, Murdoch GH, et al: Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains. J Biol Chem 271: 4077-4081, 1996.
25. Wang J, Dickson DW, Trojanowski JQ and Lee VM: The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging. Exp Neurol 158: 328-337, 1999.
26. Dwane S, Durack E and Kiely PA: Optimising parameters for the differentiation of SH-SY5Y cells to study cell adhesion and cell migration. BMC Res Notes 6: 366, 2013.
27. Petratos S, Li QX, George AJ, Hou X, Kerr ML, Unabia SE, et al: The beta-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism. Brain 131: 90-108, 2008.
28. Bachmann RA, Kim JH, Wu AL, Park IH and Chen J: A nuclear transport signal in mammalian target of rapamycin is critical for its cytoplasmic signaling to S6 kinase 1. J Biol Chem 281: 7357-7363, 2006.
29. Sanchez-Espinosa MP, Atienza M and Cantero JL: Sleep deficits in mild cognitive impairment are associated with increased plasma amyloid-beta levels and cortical thinning. Neuroimage 98: 395-404, 2014.
30. Canu E, McLaren DG, Fitzgerald ME, Bendlin BB, Zoccatelli G, Alessandrini F, et al: Mapping the structural brain changes in Alzheimer's disease: The independent contribution of two imaging modalities. J Alzheimers Dis 26 (Suppl 3): S263-S274, 2011.
31. Banno K, Nakaaki S, Sato J, Torii K, Narumoto J, Miyata J, et al: Neural basis of three dimensions of agitated behaviors in patients with Alzheimer disease. Neuropsychiatr Dis Treat 10: 339-348, 2014.
32. Nagahama Y, Okina T, Suzuki N and Matsuda M: Neural correlates of psychotic symptoms in dementia with Lewy bodies. Brain 133: 557-567, 2010.
33. Bagyinszky E, Youn YC, An SS and Kim S: The genetics of Alzheimer's disease. Clin Interv Aging 9: 535-551, 2014.
34. Borovecki F, Klepac N, Muck-Seler D, Hajnsek S, Mubrin Z and Pivac N: Unraveling the biological mechanisms in Alzheimer's disease-lessons from genomics. Prog Neuropsychopharmacol Biol Psychiatry 35: 340-37, 2010.
35. Caccamo A, Maldonado MA, Majumder S, Medina DX, Holbein W, Magri A, et al: Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism. J Biol Chem 286: 8924-8932, 2011.
36. Cai Z, Zhao B, Li K, Zhang L, Li C, Quazi SH, et al: Mammalian target of rapamycin: A valid therapeutic target through the autophagy pathway for Alzheimer's disease? J Neurosci Res 90: 1105-1118, 2012.